ME03294B - Primena cirkonijum silikata za tretman hiperkalemije - Google Patents
Primena cirkonijum silikata za tretman hiperkalemijeInfo
- Publication number
- ME03294B ME03294B MEP-2019-26A MEP201926A ME03294B ME 03294 B ME03294 B ME 03294B ME P201926 A MEP201926 A ME P201926A ME 03294 B ME03294 B ME 03294B
- Authority
- ME
- Montenegro
- Prior art keywords
- hyperkalemia
- treatment
- zirconium silicate
- zirconium
- silicate
- Prior art date
Links
- 208000002682 Hyperkalemia Diseases 0.000 title 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G25/00—Compounds of zirconium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0006—Controlling or regulating processes
- B01J19/0013—Controlling the temperature of the process
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0053—Details of the reactor
- B01J19/006—Baffles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0053—Details of the reactor
- B01J19/0066—Stirrers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/18—Stationary reactors having moving elements inside
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/02—Processes using inorganic exchangers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/08—Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/14—Base exchange silicates, e.g. zeolites
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/20—Silicates
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B39/00—Compounds having molecular sieve and base-exchange properties, e.g. crystalline zeolites; Their preparation; After-treatment, e.g. ion-exchange or dealumination
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B39/00—Compounds having molecular sieve and base-exchange properties, e.g. crystalline zeolites; Their preparation; After-treatment, e.g. ion-exchange or dealumination
- C01B39/02—Crystalline aluminosilicate zeolites; Isomorphous compounds thereof; Direct preparation thereof; Preparation thereof starting from a reaction mixture containing a crystalline zeolite of another type, or from preformed reactants; After-treatment thereof
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B39/00—Compounds having molecular sieve and base-exchange properties, e.g. crystalline zeolites; Their preparation; After-treatment, e.g. ion-exchange or dealumination
- C01B39/02—Crystalline aluminosilicate zeolites; Isomorphous compounds thereof; Direct preparation thereof; Preparation thereof starting from a reaction mixture containing a crystalline zeolite of another type, or from preformed reactants; After-treatment thereof
- C01B39/06—Preparation of isomorphous zeolites characterised by measures to replace the aluminium or silicon atoms in the lattice framework by atoms of other elements, i.e. by direct or secondary synthesis
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B39/00—Compounds having molecular sieve and base-exchange properties, e.g. crystalline zeolites; Their preparation; After-treatment, e.g. ion-exchange or dealumination
- C01B39/02—Crystalline aluminosilicate zeolites; Isomorphous compounds thereof; Direct preparation thereof; Preparation thereof starting from a reaction mixture containing a crystalline zeolite of another type, or from preformed reactants; After-treatment thereof
- C01B39/46—Other types characterised by their X-ray diffraction pattern and their defined composition
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/025—Silicon compounds without C-silicon linkages
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00049—Controlling or regulating processes
- B01J2219/00051—Controlling the temperature
- B01J2219/00054—Controlling or regulating the heat exchange system
- B01J2219/00056—Controlling or regulating the heat exchange system involving measured parameters
- B01J2219/00058—Temperature measurement
- B01J2219/00063—Temperature measurement of the reactants
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00049—Controlling or regulating processes
- B01J2219/00051—Controlling the temperature
- B01J2219/00074—Controlling the temperature by indirect heating or cooling employing heat exchange fluids
- B01J2219/00087—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor
- B01J2219/00094—Jackets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00761—Details of the reactor
- B01J2219/00763—Baffles
- B01J2219/00765—Baffles attached to the reactor wall
- B01J2219/00768—Baffles attached to the reactor wall vertical
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/80—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
- C01P2002/82—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by IR- or Raman-data
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/51—Particles with a specific particle size distribution
- C01P2004/52—Particles with a specific particle size distribution highly monodisperse size distribution
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/61—Micrometer sized, i.e. from 1-100 micrometer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Geology (AREA)
- General Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161441893P | 2011-02-11 | 2011-02-11 | |
PCT/US2012/024727 WO2012109590A2 (en) | 2011-02-11 | 2012-02-10 | Microporous zirconium silicate for the treatment of hyperkalemia |
EP12744254.9A EP2673237B1 (en) | 2011-02-11 | 2012-02-10 | Use of a zirconium silicate for the treatment of hyperkalemia |
Publications (1)
Publication Number | Publication Date |
---|---|
ME03294B true ME03294B (me) | 2019-07-20 |
Family
ID=46639226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-2019-26A ME03294B (me) | 2011-02-11 | 2012-02-10 | Primena cirkonijum silikata za tretman hiperkalemije |
Country Status (30)
Country | Link |
---|---|
US (15) | US8802152B2 (me) |
EP (3) | EP2673237B1 (me) |
JP (3) | JP6071906B2 (me) |
KR (1) | KR101896732B1 (me) |
CN (3) | CN109106725A (me) |
AU (3) | AU2012214224B2 (me) |
BR (1) | BR112013020533A2 (me) |
CA (1) | CA2827056C (me) |
CL (2) | CL2013002337A1 (me) |
CO (1) | CO6801733A2 (me) |
CY (2) | CY1121310T1 (me) |
DK (1) | DK2673237T3 (me) |
ES (1) | ES2709004T3 (me) |
HK (1) | HK1247178A1 (me) |
HR (1) | HRP20190146T1 (me) |
HU (2) | HUE041828T2 (me) |
IL (3) | IL227907A (me) |
LT (2) | LT2673237T (me) |
LU (1) | LUC00111I2 (me) |
ME (1) | ME03294B (me) |
MX (2) | MX341822B (me) |
NL (1) | NL300976I2 (me) |
NO (1) | NO2019022I1 (me) |
PL (1) | PL2673237T3 (me) |
PT (1) | PT2673237T (me) |
RS (1) | RS58490B1 (me) |
SI (1) | SI2673237T1 (me) |
TR (1) | TR201901002T4 (me) |
WO (1) | WO2012109590A2 (me) |
ZA (1) | ZA201306240B (me) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2012214224B2 (en) | 2011-02-11 | 2016-03-17 | Zs Pharma, Inc | Microporous zirconium silicate for the treatment of hyperkalemia |
US9943637B2 (en) | 2012-06-11 | 2018-04-17 | ZS Pharma, Inc. | Microporous zirconium silicate and its method of production |
CN104968336A (zh) * | 2012-07-11 | 2015-10-07 | Zs制药公司 | 用于治疗高钙血症患者高钾血症的微孔硅酸锆以及用于治疗高钾血症的改进的含钙组合物 |
WO2014058905A2 (en) * | 2012-10-08 | 2014-04-17 | Relypsa, Inc. | Potassium-binding agents for treating hypertension and hyperkalemia |
AU2013334776B2 (en) | 2012-10-22 | 2017-08-31 | ZS Pharma, Inc. | Microporous zirconium silicate for treating hyperkalemia |
US20150359821A1 (en) * | 2012-10-22 | 2015-12-17 | ZS Pharma, Inc. | Microporous Zirconium Silicate for the Treatment of Hyperkalemia |
US10695365B2 (en) | 2012-10-22 | 2020-06-30 | ZS Pharma, Inc. | Microporous zirconium silicate for the treatment of hyperkalemia |
TWI655948B (zh) * | 2013-03-15 | 2019-04-11 | 美商Zs藥品公司 | 用於高血鉀治療之微孔矽酸鋯 |
EP2981272B1 (en) * | 2013-04-05 | 2023-03-01 | ZS Pharma, Inc | Microporous zirconium silicate and diuretics for the reduction of potassium and treatment of chronic kidney and/or chronic heart disease |
CN106170283B (zh) * | 2013-11-08 | 2019-08-20 | Zs制药公司 | 用于治疗高钾血症的微孔硅酸锆 |
AU2014346572A1 (en) * | 2013-11-08 | 2016-06-09 | ZS Pharma, Inc. | Microporous zirconium silicate for the treatment of hyperkalemia |
US20160038538A1 (en) * | 2013-11-08 | 2016-02-11 | ZS Pharma, Inc. | Microporous zirconium silicate for the treatment of hyperkalemia |
JP2016540010A (ja) * | 2013-12-10 | 2016-12-22 | ズィーエス・ファーマ,インコーポレーテッド | リチウム非共投与における高カリウム血症治療用ケイ酸ジルコニウム |
US9592253B1 (en) * | 2015-10-14 | 2017-03-14 | ZS Pharma, Inc. | Extended use zirconium silicate compositions and methods of use thereof |
US10668098B2 (en) | 2017-07-07 | 2020-06-02 | Hemocleanse Technology Llc | Oral sorbent for removing toxins of kidney failure combining anion and cation exchangers |
WO2019092179A1 (en) | 2017-11-10 | 2019-05-16 | Sandoz Ag | Pharmaceutical compositions comprising zs-9 |
US11524102B2 (en) | 2018-07-27 | 2022-12-13 | Fresenius Medical Care Holdings, Inc. | System for tailoring dialysis treatment based on sensed potassium concentration, patient data, and population data |
WO2020182927A1 (en) | 2019-03-13 | 2020-09-17 | Astrazeneca Ab | Potassium-binding agents for use in hemodialysis patients |
US11964266B2 (en) | 2019-07-09 | 2024-04-23 | Uop Llc | Process for removing cobalt, lead, cadmium and chromium ions from bodily fluids using metallate ion exchange compositions |
US11577014B2 (en) | 2019-07-09 | 2023-02-14 | Uop Llc | Process for removing strontium ions from bodily fluids using metallate ion exchange compositions |
US11484875B2 (en) | 2019-07-09 | 2022-11-01 | Uop Llc | Process for removing mercury ions from bodily fluids using titanium metallate ion exchange compositions |
WO2021199239A1 (ja) | 2020-03-31 | 2021-10-07 | 興和株式会社 | 包装体入り含水組成物 |
US12036528B2 (en) | 2020-09-30 | 2024-07-16 | Uop Llc | Process for removing lead ions from boldily fluids using metallate ion exchange compositions |
CN112591758B (zh) * | 2021-01-08 | 2022-10-28 | 景德镇皓旭陶瓷原料有限公司 | 一种锆渣中锆硅高效回收利用的方法 |
Family Cites Families (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE21224E (en) * | 1939-10-03 | Coherent zirconium silicates | ||
US3329480A (en) | 1963-10-18 | 1967-07-04 | Union Oil Co | Crystalline zircono-silicate zeolites |
US3947279A (en) | 1971-12-23 | 1976-03-30 | Owens-Illinois, Inc. | Thermally crystallizable glasses possessing precision controlled crystallization and flow properties and process of producing same |
US3898318A (en) * | 1973-11-14 | 1975-08-05 | Philadelphia Quartz Co | Silicate dissolving |
US4581141A (en) | 1978-02-27 | 1986-04-08 | Purdue Research Foundation | Dialysis material and method for removing uremic substances |
FR2444005A1 (fr) | 1978-12-15 | 1980-07-11 | Ugine Kuhlmann | Procede industriel de fabrication en semi-continu de zeolithe a |
US4374093A (en) * | 1981-02-20 | 1983-02-15 | Mobil Oil Corporation | Continuous-stream upflow zeolite crystallization apparatus |
JPS6046915A (ja) * | 1983-08-24 | 1985-03-14 | Taki Chem Co Ltd | 合成無定形ジルコニウム結合珪酸塩及びその製造方法 |
US4908832A (en) | 1985-05-01 | 1990-03-13 | Spectra-Physics, Inc. | High efficiency mode-matched solid-state laser with transverse pumping |
US4943545A (en) | 1987-06-08 | 1990-07-24 | Mobil Oil Corporation | Activation of zeolites |
US5032556A (en) | 1989-02-21 | 1991-07-16 | Tosoh Corporation | Preparation method for zircon powder |
US5015453A (en) | 1989-04-28 | 1991-05-14 | W. R. Grace & Co.-Conn. | Crystalline group IVA metal-containing molecular sieve compositions |
JP3265344B2 (ja) | 1990-03-16 | 2002-03-11 | 東ソー株式会社 | ジルコン粉末の合成法 |
JP2756174B2 (ja) * | 1990-08-07 | 1998-05-25 | 神鋼パンテツク株式会社 | 撹拌装置 |
CN1070625A (zh) * | 1991-11-05 | 1993-04-07 | 徐振江 | 提纯硅酸锆(铪)的方法 |
US5338527A (en) | 1992-08-20 | 1994-08-16 | Uop | Zirconium silicate composition, method of preparation and uses thereof |
ATE142170T1 (de) | 1992-10-28 | 1996-09-15 | Crosfield Joseph & Sons | Kieselsäuren |
US5518707A (en) | 1994-10-24 | 1996-05-21 | Uop | Metallo germanates |
GB9601398D0 (en) | 1996-01-24 | 1996-03-27 | Piper Edwina M | Composition |
IT1283284B1 (it) | 1996-03-21 | 1998-04-16 | Eniricerche Spa | Zeolite ers-10 e procedimento per la sua preparazione |
FR2750893B1 (fr) | 1996-07-12 | 1998-10-30 | Elf Aquitaine | Procede de synthese de zeolithe avec agitation homogene du milieu, dispositif et application |
CA2214495C (en) | 1996-09-25 | 2002-02-05 | Daniel L. Woodard | Hydrated zirconium silicate composition for purification of nucleic acids |
US5891417A (en) | 1997-04-08 | 1999-04-06 | Uop Llc | Zirconium silicate and zirconium germanate molecular sieves and process using the same |
US5888472A (en) | 1997-04-08 | 1999-03-30 | Uop Llc | Zirconium silicate molecular sieves and process using the same |
CA2268888A1 (en) | 1997-05-12 | 1998-11-19 | Itsuki Uehara | Separator for battery and alkali secondary battery using the same |
US6007790A (en) | 1998-08-13 | 1999-12-28 | Uop Llc | Family of microporous indium silicate compositions |
EP1038580B1 (en) * | 1999-03-26 | 2005-05-25 | Uop Llc | Ammonium ion adsorption process using zirconium silicate and zirconium germanate molecular sieves |
US6332985B1 (en) | 1999-03-29 | 2001-12-25 | Uop Llc | Process for removing toxins from bodily fluids using zirconium or titanium microporous compositions |
US6099737A (en) * | 1999-03-29 | 2000-08-08 | Uop Llc | Process for removing toxins from blood using zirconium metallate or titanium metallate compositions |
US7041274B2 (en) | 1999-10-22 | 2006-05-09 | Intevep, S.A. | Aluminosilicate compositions, preparation and use |
US20020061521A1 (en) * | 2000-01-31 | 2002-05-23 | Rosen Craig A. | Nucleic acids, proteins, and antibodies |
DE60103260T2 (de) * | 2000-03-17 | 2005-05-19 | PQ Holding, Inc., Wilmington | Verfahren zur herstellung von zeoliten und zeolitenmischungen mit verbesserten kationenaustauscheigenschaft sowie dadurch hergestellte produkte und waschmittelzusammensetzungen |
US6379641B1 (en) | 2000-05-01 | 2002-04-30 | Uop Llc | Microporous rare earth silicates and method of producing same |
US6596254B1 (en) | 2000-06-12 | 2003-07-22 | Sandia Corporation | Niobate-based octahedral molecular sieves |
WO2002004086A1 (en) * | 2000-07-12 | 2002-01-17 | Uop Llc | Process for removing toxins from bodily fluids using zirconium or titanium microporous compositions |
WO2002062356A2 (en) * | 2001-02-06 | 2002-08-15 | Ash Medical Systems, Inc. | Monovalent-selective cation exchangers as oral sorbent therapy |
US6579460B1 (en) | 2001-03-13 | 2003-06-17 | Uop Llc | Process and composition for removing toxins from bodily fluids |
US6814871B1 (en) * | 2001-07-13 | 2004-11-09 | Uop Llc | Process for removing pollutants from aqueous streams |
ITMI20021246A1 (it) | 2002-06-07 | 2003-12-09 | Geomedical S R L | Composizioni minerali detossinanti a base di zeoliti ad elevata capacita' di scambio cationico |
US6689335B1 (en) | 2002-12-19 | 2004-02-10 | Eastman Kodak Company | Silver ion sequester and release agent |
US20050106267A1 (en) | 2003-10-20 | 2005-05-19 | Framework Therapeutics, Llc | Zeolite molecular sieves for the removal of toxins |
US6984403B2 (en) | 2003-12-04 | 2006-01-10 | Pfizer Inc. | Azithromycin dosage forms with reduced side effects |
US8597778B2 (en) | 2003-12-15 | 2013-12-03 | Asahi Kasei Chemicals Corporation | Porous formed article and method for production thereof |
US7556799B2 (en) | 2004-03-30 | 2009-07-07 | Relypsa, Inc. | Ion binding polymers and uses thereof |
KR101228233B1 (ko) | 2004-03-30 | 2013-01-31 | 리립사, 인크. | 이온 결합 중합체 및 이의 용도 |
US8282960B2 (en) | 2004-03-30 | 2012-10-09 | Relypsa, Inc. | Ion binding compositions |
US7854924B2 (en) | 2004-03-30 | 2010-12-21 | Relypsa, Inc. | Methods and compositions for treatment of ion imbalances |
US8192758B2 (en) | 2004-03-30 | 2012-06-05 | Relypsa, Inc. | Ion binding compositions |
CN100351202C (zh) * | 2004-09-03 | 2007-11-28 | 佛山欧神诺陶瓷有限公司 | 一种可释放负离子的健康陶瓷砖生产方法 |
US7566432B2 (en) | 2004-12-28 | 2009-07-28 | Renal Solutions, Inc. | Method of synthesizing zirconium phosphate particles |
US7967984B2 (en) | 2005-06-14 | 2011-06-28 | Asahi Kasei Chemicals Corporation | Apparatus for water treatment and method of treating water |
DE112006002617T5 (de) | 2005-09-30 | 2008-08-28 | Ilypsa Inc., Santa Clara | Verfahren zur Herstellung von Core-Shell-Kompositen bzw. Kern-Hüllen-Kompositen mit vernetzten Hüllen und daraus entstehende Core-Shell-Komposite |
WO2007041569A1 (en) | 2005-09-30 | 2007-04-12 | Ilypsa, Inc. | Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal |
US8367112B2 (en) * | 2006-02-28 | 2013-02-05 | Alkermes Pharma Ireland Limited | Nanoparticulate carverdilol formulations |
WO2007127390A2 (en) | 2006-04-28 | 2007-11-08 | Biolife, L.L.C. | Materials and methods for wound treatment |
WO2008070072A2 (en) | 2006-12-01 | 2008-06-12 | Mutual Pharmaceutical Company, Inc. | Carvedilol forms, compositions, and methods of preparation thereof |
WO2008082087A1 (en) | 2007-01-03 | 2008-07-10 | Insilicotech Co., Ltd | Coordination polymer crystal with porous metal-organic frameworks and preperation method thereof |
ES2304890B1 (es) * | 2007-04-03 | 2009-10-30 | Universidad De Zaragoza | Procedimiento de obtencion de esferas de titanosilicato. |
DE202009018723U1 (de) | 2008-02-26 | 2012-11-20 | Corning Inc. | Läutermittel für Silikatgläser |
LT2957286T (lt) | 2008-08-22 | 2018-12-10 | Vifor (International) Ltd. | Susiūti katijonų mainų polimerai, kompozicijos ir panaudojimas hiperkalemijos gydyme |
WO2010022381A1 (en) * | 2008-08-22 | 2010-02-25 | Relypsa, Inc. | Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties |
CN101502815B (zh) * | 2009-02-26 | 2010-09-29 | 江苏拜富色釉料有限公司 | 一种硅酸锆的制备方法 |
CA2765033C (en) | 2009-06-12 | 2020-07-14 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
US8865121B2 (en) | 2009-06-18 | 2014-10-21 | Basf Se | Organotemplate-free synthetic process for the production of a zeolitic material |
US20120070468A1 (en) | 2010-09-16 | 2012-03-22 | Uop Llc | Removal of toxins from gastrointestinal fluids |
AU2012214224B2 (en) * | 2011-02-11 | 2016-03-17 | Zs Pharma, Inc | Microporous zirconium silicate for the treatment of hyperkalemia |
WO2012137132A1 (en) | 2011-04-08 | 2012-10-11 | Basf Se | Process for producing acylation catalyst |
US10092688B2 (en) | 2011-05-13 | 2018-10-09 | Laura Jean Robinson | Medicament kit and method of use |
US9527751B2 (en) | 2011-11-11 | 2016-12-27 | Basf Se | Organotemplate-free synthetic process for the production of a zeolitic material of the CHA-type structure |
JP2015510484A (ja) | 2012-02-06 | 2015-04-09 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | 有機鋳型を用いない合成からの鉄及び銅含有ゼオライトベータ、及びそのNOxの選択的触媒還元における使用方法 |
US9475041B2 (en) | 2012-04-24 | 2016-10-25 | Basf Se | Zeolitic materials and methods for their preparation using alkenyltrialkylammonium compounds |
US9943637B2 (en) | 2012-06-11 | 2018-04-17 | ZS Pharma, Inc. | Microporous zirconium silicate and its method of production |
CN104968336A (zh) | 2012-07-11 | 2015-10-07 | Zs制药公司 | 用于治疗高钙血症患者高钾血症的微孔硅酸锆以及用于治疗高钾血症的改进的含钙组合物 |
US10695365B2 (en) | 2012-10-22 | 2020-06-30 | ZS Pharma, Inc. | Microporous zirconium silicate for the treatment of hyperkalemia |
AU2013334776B2 (en) | 2012-10-22 | 2017-08-31 | ZS Pharma, Inc. | Microporous zirconium silicate for treating hyperkalemia |
EP2981272B1 (en) | 2013-04-05 | 2023-03-01 | ZS Pharma, Inc | Microporous zirconium silicate and diuretics for the reduction of potassium and treatment of chronic kidney and/or chronic heart disease |
AU2014346572A1 (en) | 2013-11-08 | 2016-06-09 | ZS Pharma, Inc. | Microporous zirconium silicate for the treatment of hyperkalemia |
US20160038538A1 (en) | 2013-11-08 | 2016-02-11 | ZS Pharma, Inc. | Microporous zirconium silicate for the treatment of hyperkalemia |
US9592253B1 (en) | 2015-10-14 | 2017-03-14 | ZS Pharma, Inc. | Extended use zirconium silicate compositions and methods of use thereof |
-
2012
- 2012-02-10 AU AU2012214224A patent/AU2012214224B2/en active Active
- 2012-02-10 PT PT12744254T patent/PT2673237T/pt unknown
- 2012-02-10 MX MX2013009271A patent/MX341822B/es active IP Right Grant
- 2012-02-10 CN CN201810959928.0A patent/CN109106725A/zh active Pending
- 2012-02-10 RS RS20190096A patent/RS58490B1/sr unknown
- 2012-02-10 PL PL12744254T patent/PL2673237T3/pl unknown
- 2012-02-10 CA CA2827056A patent/CA2827056C/en active Active
- 2012-02-10 KR KR1020137023967A patent/KR101896732B1/ko active IP Right Grant
- 2012-02-10 LT LTEP12744254.9T patent/LT2673237T/lt unknown
- 2012-02-10 ME MEP-2019-26A patent/ME03294B/me unknown
- 2012-02-10 TR TR2019/01002T patent/TR201901002T4/tr unknown
- 2012-02-10 US US13/371,080 patent/US8802152B2/en active Active
- 2012-02-10 SI SI201231513T patent/SI2673237T1/sl unknown
- 2012-02-10 DK DK12744254.9T patent/DK2673237T3/en active
- 2012-02-10 EP EP12744254.9A patent/EP2673237B1/en active Active
- 2012-02-10 ES ES12744254T patent/ES2709004T3/es active Active
- 2012-02-10 JP JP2013553608A patent/JP6071906B2/ja active Active
- 2012-02-10 BR BR112013020533A patent/BR112013020533A2/pt not_active Application Discontinuation
- 2012-02-10 EP EP17175312.2A patent/EP3246287A1/en active Pending
- 2012-02-10 CN CN201280017682.6A patent/CN103534209A/zh active Pending
- 2012-02-10 HU HUE12744254A patent/HUE041828T2/hu unknown
- 2012-02-10 CN CN201810963634.5A patent/CN108969535A/zh active Pending
- 2012-02-10 EP EP18195925.5A patent/EP3470370A1/en active Pending
- 2012-02-10 WO PCT/US2012/024727 patent/WO2012109590A2/en active Application Filing
-
2013
- 2013-08-09 MX MX2016011293A patent/MX354456B/es unknown
- 2013-08-11 IL IL227907A patent/IL227907A/en active Protection Beyond IP Right Term
- 2013-08-12 CL CL2013002337A patent/CL2013002337A1/es unknown
- 2013-08-19 ZA ZA2013/06240A patent/ZA201306240B/en unknown
- 2013-08-28 CO CO13204047A patent/CO6801733A2/es not_active Application Discontinuation
- 2013-09-25 US US14/036,489 patent/US8808750B2/en active Active
-
2014
- 2014-03-26 US US14/226,279 patent/US9457050B2/en active Active
- 2014-07-01 US US14/321,678 patent/US20140377560A1/en not_active Abandoned
- 2014-07-01 US US14/321,634 patent/US9662352B2/en active Active
- 2014-07-01 US US14/321,659 patent/US9844567B2/en active Active
- 2014-08-01 US US14/450,126 patent/US20140342017A1/en not_active Abandoned
-
2015
- 2015-03-31 US US14/659,043 patent/US20150196592A1/en not_active Abandoned
- 2015-04-21 US US14/692,287 patent/US10413569B2/en active Active
- 2015-08-13 US US14/826,011 patent/US10398730B2/en active Active
- 2015-08-13 US US14/826,038 patent/US9861658B2/en active Active
-
2016
- 2016-03-22 IL IL244704A patent/IL244704A/en active IP Right Grant
- 2016-05-13 CL CL2016001166A patent/CL2016001166A1/es unknown
- 2016-06-17 AU AU2016204124A patent/AU2016204124B2/en active Active
- 2016-09-01 US US15/254,688 patent/US10335432B2/en active Active
- 2016-11-01 JP JP2016214142A patent/JP6251354B2/ja active Active
- 2016-12-26 JP JP2016250523A patent/JP2017105706A/ja active Pending
-
2017
- 2017-10-15 IL IL255025A patent/IL255025A0/en unknown
- 2017-10-27 AU AU2017251826A patent/AU2017251826A1/en not_active Abandoned
- 2017-11-08 US US15/807,352 patent/US20180125884A1/en not_active Abandoned
-
2018
- 2018-05-21 HK HK18106615.2A patent/HK1247178A1/zh unknown
-
2019
- 2019-01-22 HR HRP20190146TT patent/HRP20190146T1/hr unknown
- 2019-01-24 CY CY20191100098T patent/CY1121310T1/el unknown
- 2019-03-19 CY CY2019015C patent/CY2019015I1/el unknown
- 2019-03-25 LU LU00111C patent/LUC00111I2/fr unknown
- 2019-03-27 NL NL300976C patent/NL300976I2/nl unknown
- 2019-04-02 HU HUS1900019C patent/HUS1900019I1/hu unknown
- 2019-04-05 LT LTPA2019010C patent/LTPA2019010I1/lt unknown
- 2019-05-02 NO NO2019022C patent/NO2019022I1/no unknown
-
2020
- 2020-04-16 US US16/850,468 patent/US11406662B2/en active Active
-
2022
- 2022-06-30 US US17/855,758 patent/US20230181631A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1900019I1 (hu) | Cirkónium-szilikát alkalmazása hiperkalémia kezelésére | |
EP2673286A4 (en) | THERAPEUTIC COMPOUNDS | |
AP3544A (en) | Compounds for the treatment of addiction | |
EP2663304A4 (en) | COMBINATION THERAPY | |
EP2742965A4 (en) | TREATMENT TOOL | |
HK1211494A1 (en) | Microporous zirconium silicate for treating hyperkalemia | |
HK1209029A1 (en) | Zirconium silicate for treatment of hyperkalemia | |
EP2934519A4 (en) | THIAZOLIDINONE THERAPEUTIC COMPOUNDS | |
ZA201207838B (en) | Use of zirconium or of a zirconium-comprising mixture | |
GB201102913D0 (en) | Novel therapeutic | |
IL236873A0 (en) | therapeutic compounds | |
LU91865B1 (en) | Process activating unit | |
GB201110895D0 (en) | Therapeutic use | |
GB201116945D0 (en) | Hand massager | |
GB201212906D0 (en) | Sonic flosser | |
IL216464A0 (en) | Hygaehis scehtep disposable can | |
GB201120096D0 (en) | Novel therapy | |
GB201108848D0 (en) | Cycles | |
GB201108846D0 (en) | Cycles | |
GB201114063D0 (en) | Kidz safe | |
GB201101807D0 (en) | Modified medical tool |